Infrequent “chronic lymphocytic leukemia-specific” immunoglobulin stereotypes in aged individuals with or without low-count monoclonal B-cell lymphocytosis

• Andreas Agathangelidis,
• Chrysi Galigalidou,
• Lydia Scarfò,
• Theodoros Moysiadis,
• Alessandra Rovida,
• Maria Gounari,
• Fotis Psomopoulos,
• Pamela Ranghetti,
• Alex Galanis,
• Frederic Davi,
• Kostas Stamatopoulos,
• Anastasia Chatzidimitriou,
• Paolo Ghia

Affiliations

Andreas Agathangelidis

Division of Experimental Oncology, Università Vita-Salute, Ospedale San Raffaele, Milan, Italy;

Chrysi Galigalidou

Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;

Lydia Scarfò

Division of Experimental Oncology, Università Vita-Salute, Ospedale San Raffaele, Milan, Italy;

Theodoros Moysiadis

Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;

Alessandra Rovida

Division of Experimental Oncology, Università Vita-Salute, Ospedale San Raffaele, Milan, Italy;

Maria Gounari

Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;

Fotis Psomopoulos

Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;

Pamela Ranghetti

Division of Experimental Oncology, Università Vita-Salute, Ospedale San Raffaele, Milan, Italy;

Alex Galanis

Dept. of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece;

Frederic Davi

Biological Hematology, Hopital Pitié-Salpetriere, Sorbonne Université, Paris, France

Kostas Stamatopoulos

Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;

Anastasia Chatzidimitriou

Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;

Paolo Ghia

Division of Experimental Oncology, Università Vita-Salute, Ospedale San Raffaele, Milan, Italy;